Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease
NCT07480720 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-03-18
Summary
This retrospective observational study aims to evaluate the relationship between systemic inflammatory parameters, thyroid autoimmunity markers, and neuroretinal structures in patients with Graves disease. Medical records of patients diagnosed with Graves disease and healthy control subjects evaluated at Elazığ Fethi Sekin City Hospital between August 2018 and January 2026 will be reviewed. Optical coherence tomography (OCT) measurements, including macular thickness and peripapillary retinal nerve fiber layer (RNFL) thickness, will be analyzed. Laboratory parameters such as complete blood count-derived inflammatory indices, C-reactive protein, thyroid function tests, and thyroid autoantibodies will also be recorded. The study will compare neuroretinal parameters between healthy controls, Graves disease patients without ophthalmopathy, and Graves disease patients with ophthalmopathy, and will investigate potential associations between systemic inflammation, thyroid autoimmunity, and neuroretinal structural changes.
Conditions
- Graves Disease
- Graves Ophthalmopathy
Sponsors & Collaborators
-
Elazıg Fethi Sekin Sehir Hastanesi
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-01
- Primary Completion
- 2026-04-01
- Completion
- 2026-05-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
NCT03498417 ·Status: COMPLETED
-
Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
NCT06081439 ·Status: RECRUITING
-
The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
NCT01056419 ·Status: UNKNOWN ·Phase: PHASE4
-
Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
NCT02210741 ·Status: UNKNOWN
-
TSI and Its Relationship With Graves' Disease Relapse
NCT05713097 ·Status: COMPLETED
-
Graves' Orbitopathy and Hypercholesterolemia
NCT02721992 ·Status: COMPLETED
-
Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy
NCT02203682 ·Status: UNKNOWN ·Phase: PHASE2
-
Incidence of Graves' Disease After COVID-19 Vaccination
NCT07213141 ·Status: ACTIVE_NOT_RECRUITING
-
Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy
NCT07124572 ·Status: RECRUITING
-
Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients
NCT04659200 ·Status: COMPLETED
-
Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.
NCT07059507 ·Status: RECRUITING
-
Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
NCT00004660 ·Status: COMPLETED ·Phase: NA
-
Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
NCT01182584 ·Status: UNKNOWN
-
Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease
NCT05643365 ·Status: RECRUITING
-
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
NCT00430547 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic Parameters in Euthyroid Patients With Thyroid Nodules
NCT00507897 ·Status: TERMINATED
-
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
NCT07152340 ·Status: RECRUITING ·Phase: PHASE4
-
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves' Disease
NCT00505011 ·Status: COMPLETED
-
T and B Cells in Graves' Orbitopathy
NCT03195296 ·Status: COMPLETED
-
Changes in Orbital Macrovascular and Intraocular Microvascular Blood Flow After Orbital Decompression Surgery in Patients With Thyroid Eye Disease
NCT07393230 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
NCT07152366 ·Status: RECRUITING ·Phase: PHASE4
-
Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction
NCT04346992 ·Status: COMPLETED
-
Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
NCT07129642 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
NCT05461820 ·Status: RECRUITING ·Phase: PHASE4